Global Personalized Cancer Medicine Competitive Landscape Professional Research Report 2024

Research Summary

Personalized cancer medicine, also known as precision oncology or personalized oncology, refers to an approach to cancer treatment that takes into account the unique genetic and molecular characteristics of an individual's cancer to tailor therapies specifically to that patient. This approach recognizes that cancer is not a single disease but rather a complex group of diseases with diverse underlying genetic mutations and molecular alterations. By analyzing the genetic profile of a patient's tumor through techniques such as genomic sequencing, molecular profiling, and biomarker analysis, oncologists can identify specific genetic mutations or biomarkers driving the cancer's growth and progression. Based on this information, personalized treatment plans can be developed to target the underlying molecular abnormalities with precision-targeted therapies such as targeted therapies, immunotherapies, or combination therapies. Personalized cancer medicine aims to maximize treatment efficacy while minimizing side effects by selecting therapies that are most likely to be effective for each individual patient based on their unique tumor biology. This approach has revolutionized cancer care by allowing for more precise and effective treatments, leading to improved outcomes and quality of life for many cancer patients.

According to DIResearch's in-depth investigation and research, the global Personalized Cancer Medicine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Personalized Cancer Medicine include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Personalized Cancer Medicine. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Personalized Cancer Medicine market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Personalized Cancer Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Personalized Cancer Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Personalized Cancer Medicine Include:

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol-Myers Squibb

Amgen

AstraZeneca

Merck & Co

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer

GSK

Exelixis

Regeneron

Innovent

Hengrui Medicine

Personalized Cancer Medicine Product Segment Include:

Cancer Immunotherapy

Targeted Therapy

Personalized Cancer Medicine Product Application Include:

Lung Cancer

Breast Cancer

Prostate Cancer

Blood-related Cancer

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Personalized Cancer Medicine Industry PESTEL Analysis

Chapter 3: Global Personalized Cancer Medicine Industry Porter's Five Forces Analysis

Chapter 4: Global Personalized Cancer Medicine Major Regional Market Size and Forecast Analysis

Chapter 5: Global Personalized Cancer Medicine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Personalized Cancer Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Personalized Cancer Medicine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Personalized Cancer Medicine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Personalized Cancer Medicine Product by Type

1.2.1 Global Personalized Cancer Medicine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cancer Immunotherapy

1.2.3 Targeted Therapy

1.3 Personalized Cancer Medicine Product by Application

1.3.1 Global Personalized Cancer Medicine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Global Personalized Cancer Medicine Market Revenue Analysis (2019-2030)

1.5 Personalized Cancer Medicine Market Development Status and Trends

1.5.1 Personalized Cancer Medicine Industry Development Status Analysis

1.5.2 Personalized Cancer Medicine Industry Development Trends Analysis

2 Personalized Cancer Medicine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Personalized Cancer Medicine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Personalized Cancer Medicine Market Analysis by Regions

4.1 Personalized Cancer Medicine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Personalized Cancer Medicine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Personalized Cancer Medicine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Personalized Cancer Medicine Revenue Forecast by Region (2025-2030)

5 Global Personalized Cancer Medicine Market Size by Type and Application

5.1 Global Personalized Cancer Medicine Market Size by Type

5.2 Global Personalized Cancer Medicine Market Size by Application

6 North America

6.1 North America Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Personalized Cancer Medicine Market Size by Type

6.4 North America Personalized Cancer Medicine Market Size by Application

6.5 North America Personalized Cancer Medicine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Personalized Cancer Medicine Market Size by Type

7.4 Europe Personalized Cancer Medicine Market Size by Application

7.5 Europe Personalized Cancer Medicine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Personalized Cancer Medicine Market Size by Type

8.4 China Personalized Cancer Medicine Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Personalized Cancer Medicine Market Size by Type

9.4 APAC (excl. China) Personalized Cancer Medicine Market Size by Application

9.5 APAC (excl. China) Personalized Cancer Medicine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Personalized Cancer Medicine Market Size by Type

10.4 Latin America Personalized Cancer Medicine Market Size by Application

10.5 Latin America Personalized Cancer Medicine Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Personalized Cancer Medicine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Personalized Cancer Medicine Market Size by Type

11.4 Middle East & Africa Personalized Cancer Medicine Market Size by Application

11.5 Middle East & Africa Personalized Cancer Medicine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Personalized Cancer Medicine Market Revenue by Key Manufacturers (2020-2024)

12.2 Personalized Cancer Medicine Competitive Landscape Analysis and Market Dynamic

12.2.1 Personalized Cancer Medicine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 AbbVie

13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 AbbVie Personalized Cancer Medicine Product Portfolio

13.1.3 AbbVie Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Johnson & Johnson Personalized Cancer Medicine Product Portfolio

13.2.3 Johnson & Johnson Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Novartis

13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Novartis Personalized Cancer Medicine Product Portfolio

13.3.3 Novartis Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Gilead Sciences

13.4.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Gilead Sciences Personalized Cancer Medicine Product Portfolio

13.4.3 Gilead Sciences Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Roche

13.5.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Roche Personalized Cancer Medicine Product Portfolio

13.5.3 Roche Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Bristol-Myers Squibb Personalized Cancer Medicine Product Portfolio

13.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Amgen

13.7.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Amgen Personalized Cancer Medicine Product Portfolio

13.7.3 Amgen Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 AstraZeneca

13.8.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 AstraZeneca Personalized Cancer Medicine Product Portfolio

13.8.3 AstraZeneca Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Merck & Co

13.9.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Merck & Co Personalized Cancer Medicine Product Portfolio

13.9.3 Merck & Co Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Takeda

13.10.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Takeda Personalized Cancer Medicine Product Portfolio

13.10.3 Takeda Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Merck KGaA

13.11.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Merck KGaA Personalized Cancer Medicine Product Portfolio

13.11.3 Merck KGaA Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Seagen

13.12.1 Seagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Seagen Personalized Cancer Medicine Product Portfolio

13.12.3 Seagen Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Eli Lilly

13.13.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Eli Lilly Personalized Cancer Medicine Product Portfolio

13.13.3 Eli Lilly Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Ono Pharmaceutical

13.14.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Ono Pharmaceutical Personalized Cancer Medicine Product Portfolio

13.14.3 Ono Pharmaceutical Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Pfizer

13.15.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Pfizer Personalized Cancer Medicine Product Portfolio

13.15.3 Pfizer Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 GSK

13.16.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 GSK Personalized Cancer Medicine Product Portfolio

13.16.3 GSK Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Exelixis

13.17.1 Exelixis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Exelixis Personalized Cancer Medicine Product Portfolio

13.17.3 Exelixis Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Regeneron

13.18.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Regeneron Personalized Cancer Medicine Product Portfolio

13.18.3 Regeneron Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Innovent

13.19.1 Innovent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Innovent Personalized Cancer Medicine Product Portfolio

13.19.3 Innovent Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Hengrui Medicine

13.20.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Hengrui Medicine Personalized Cancer Medicine Product Portfolio

13.20.3 Hengrui Medicine Personalized Cancer Medicine Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Personalized Cancer Medicine Industry Chain Analysis

14.2 Personalized Cancer Medicine Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Personalized Cancer Medicine Typical Downstream Customers

14.4 Personalized Cancer Medicine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support